| Symbol | SDGR |
|---|---|
| Name | SCHRODINGER, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 1540 BROADWAY,24TH FLOOR, NEW YORK, New York, 10036, United States |
| Telephone | +1 212 295-5800 |
| Fax | — |
| — | |
| Website | https://www.schrodinger.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001490978 |
| Description | Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. Additional info from NASDAQ: |
Schrödinger, Inc. - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Read moreSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Read moreSchrödinger, Inc. - Schrödinger Reports Second Quarter 2026 Financial Results
Read moreSchrödinger, Inc. - Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
Read moreSchrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
Read moreSchrödinger, Inc. - Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
Read moreSchrödinger, Inc. - Schrödinger to Announce Second Quarter 2026 Financial Results on August 5
Read moreSchrödinger, Inc. - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Read moreJain Rachit 🔴 sold 875 shares of Schrodinger, Inc. (SDGR) at $15.60 Transaction Date: Jul 16, 2026 | Filing ID: 000004
Read more